Endomedix, Inc. develops hydrogel technology solutions for the medical device markets. The company focuses on tissue sealant, hemostat, and biomedical adhesive markets. It offers a biocompatible and biodegradable hydrogel used in various biomedical applications, such as general surgery, vascular surgery, neurosurgery, spine surgery, ophthalmologic surgery, and wound care applications. The companyâs products also include topical hemostat, internal hemostat, and wound care. Its products are offered in various forms, such as injectable liquid hydrogel and lyophilized foams.
